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Abstract 
Background. This study was designed to assess piperacillin tazobactam (PT) as an 
alternative to ampicillin and gentamicin (AG) in neonates with suspected systemic 
infection. 
Methods. A retrospective, unmatched population of AG (2007-2009) and PT (2009-
2012) exposed infants were evaluated for initial effectiveness, adverse events, and 
subsequent morbidities or mortality. Data included gestational age, birth weight, sex, 
Apgar score, length of hospital stay, glomerular filtration rate for days 1 and 2, duration on 
mechanical ventilation, duration on oxygen therapy, incidence of sepsis (blood or 
cerebrospinal fluid culture positive), incidence of ventilator associated pneumonia,  and 
incidence of necrotizing enterocolitis. All positive blood cultures during the study period 
were reviewed. Data about specific microorganisms and sensitivity to antibiotics were 
collected.  
Results. No significant differences in demographics or initial Apgar scores were noted. 
There were no significant differences in systemic rash or diaper rash. PT was associated 
with higher glomerular filtration rate on day two.  Four infants had early onset sepsis with 
ampicillin resistant E. coli. One of these, in the PT group, had intermediate sensitivity to 
gentamicin as well. 
Conclusion. Use of PT as the initial empiric antibiotic was not associated with increased 
adverse outcomes. The challenge of ampicillin resistant Escherichia coli should 
encourage others to consider this change. 
KS J Med 2015; 8(2):80-83. 
 
 
Introduction 
The most common antibiotic 
combination used for therapy of 
presumed early-onset neonatal sepsis is 
ampicillin and gentamicin (AG), based 
upon the rationale that the majority of 
bacterial pathogens are sensitive to this 
combination. The most prevalent gram 
positive organism is Group B 
Streptococcus, although this organism 
has been in decline coinciding with 
increased intrapartum ampicillin.1-4 The 
most frequent gram negative bacteria are 
Escherichia coli, followed by 
Haemophilus influenza and Citrobacter 
species.  
There are many concerns regarding 
the use of AG. The recommended dose 
is potentially insufficient to treat Listeria 
meningitis.5,6 Antenatal exposure and 
prolonged postnatal ampicillin exposure 
increase the risk of necrotizing 
enterocolitis (NEC).1-4,7-9  In addition, 
ampicillin increases bleeding times 
through a direct effect on platelets.1 
However, the most important concerns 
are ototoxic and renal toxic effects of 
gentamicin, gentamicin resistance in late 
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onset infection and emergence of 
ampicillin and gentamicin resistant E. 
coli.  Given the lack of controlled 
experiences, the use of PT in infants less 
than two months is not included in the 
package insert. 
Due to these concerns, our institution 
changed from AG to piperacillin-
tazobactam (PT) for routine empiric 
coverage of suspected early onset of 
sepsis. The impact of PT was monitored 
in our very low birth weight (VLBW) 
infants. Results showed no increase in 
major morbidities or significant adverse 
events. PT was associated with a 
transient increase in glomerular filtration 
rate during exposure and decreases in 
NEC and diaper rash when compared 
with AG.1 Therefore, a study was 
designed to assess whether PT was 
associated with altered outcomes in 
infants with greater than 1500 grams 
birth weight. 
Methods 
A retrospective unmatched, cohort 
study was conducted to compare 
effectiveness and safety following the 
change from AG to PT at the Wesley 
Medical Center (WMC) Neonatal 
Intensive Care Unit (NICU). WMC 
switched from AG to PT in January 2010.  
An unmatched comparison of AG 
exposed infants with PT exposed infants 
was conducted in the populations from 
two years prior (2007-2009) and three 
years after (2009-2012) the change in 
antibiotic policy. Cohorts were evaluated 
for effectiveness, congenital infection, 
adverse events, subsequent morbidities 
and mortality. During these two periods, 
there were no changes in the indications 
for initiation of antibiotic coverage.  
Data were collected from inborn infants 
with the birth weight greater than 1500 
grams, who had suspected systemic 
infection and were receiving AG 
(12/20/2007-12/31/2009) or PT 
(12/20/2009-12/31/2012). Patients with 
Methacillin Resistant Staphylococcus 
Aureus colonization were excluded from 
the study. 
Study data included gestational age, 
birth weight, sex, Apgar score, length of 
hospital stay, glomerular filtration rate 
(GFR) for days 1 and 2, duration on 
mechanical ventilation, duration on 
oxygen therapy, incidence of sepsis 
(blood or cerebrospinal fluid culture 
positive), incidence of ventilator 
associated pneumonia (clinical and 
radiographical change),  and incidence of 
NEC (clinical and radiographic changes). 
All positive blood cultures in the study 
period were reviewed. Data about 
specific microorganisms and sensitivity 
to antibiotics were reviewed and 
collected.  
Statistical methods included Mann-
Whitney U-test, t-test and analysis of 
variance (ANOVA) for nominal and 
continuous variables. Chi-square analysis 
was used for categorical variables. 
Descriptive statistics were stratified by 
group. 
Results 
A total of 1682 patients were 
identified, 653 exposed to AG and 1029 
exposed to PT. No significant 
differences in demographics or initial 
Apgar scores were noted (Table 1). 
There were no significant differences in 
systemic or diaper rash. PT was 
associated with higher GFR on day 2. 
Four infants had early onset sepsis with 
ampicillin resistant E. coli (3AG/1PT). 
One of these, in the PT group, had 
intermediate sensitivity to gentamicin as 
well. One additional PT infant had 
Haemophilus influenzae sepsis at birth 
which was sensitive to ampicillin.
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Table 1. Demographics and Apgar Scores 
Variable  AG PT Test Statistic 
N 653 1029  
Birth Weight –  25th, 50th, 75th percentile 1.88, 2.20, 2.70 1.93, 2.24, 2.72 U=1.29, p=0.20 
Gestational Age –  25th, 50th, 75th percentile 32, 34, 35.5 33, 34, 35 U=1.32, p=0.19 
Male – N (%) 356 (55%) 590 (57%) X2(1)=1.29, p=0.26 
Caesarian - N (%) 348 (53%) 565 (55%) X2(1)=0.38, p=0.54 
Apgar <7 at 1 minute –  N (%) 232 (36%) 357 (35%) X2(1)=0.10, p=0.75 
Apgar <7 at 5 minutes - N (%) 66 (10%) 107 (10%) X2(1)=0.04, p=0.85 
GFR day 1 –  25th, 50th, 75th percentile 13.86, 16.02, 18.45 14.49, 16.56, 18.9 U=2.692, p=0.007 
GFR day 2 –  25th, 50th, 75th percentile 11.34, 13.55, 15.48 12.57, 15.12, 17.82 U=6.612, p<0.001 
Mortality - N (%) 7 (1%) 12 (1%) X2(1)=0.03, p=0.86 
NEC - N (%) 4 (0.6%) 4 (0.4%) X2(1)=0.42, p=0.52 
 
Discussion 
PT as an empiric choice for 
suspected neonatal sepsis was not 
associated with any adverse outcome 
and can be used successfully as a 
monotherapy. Patients receiving AG had 
a lower GFR, consistent with our 
previous study in which this was 
transient and not sustained.1 We did not 
abstract GFR beyond the exposure 
period. There are some limitations to this 
study. It is a retrospective, unmatched 
comparison study, and as such cannot be 
used to assert causation. However, in our 
previous study,1 matching did not alter 
results; therefore, we determined it was 
necessary for the present study. The 
current challenge of ampicillin resistant 
E. coli should encourage others to 
consider this change. 
Acknowledgments 
The Wichita Medical Research and 
Education Foundation funded and its 
IRB approved this project. We 
appreciate the contributions of Jared 
Shaw, Paula Delmore, Joy Nimeskern as 
well as the staff of the NICU and 
Administration at Wesley Medical 
Center.  
 
References 
1 Chong E, Reynolds J, Shaw J, et al. 
Results of a two-center, before and 
after study of piperacillin–tazobactam 
versus ampicillin and gentamicin as 
empiric therapy for suspected sepsis at 
birth in neonates ≤ 1500 g. J Perinatol 
2013; 33(7):529-532. PMID: 
23328923. 
Kansas Journal of Medicine 2015    Comparative Effectiveness and Safety in the NICU   
83  
2 Stoll BJ, Hansen N, Fanaroff AA, et al. 
Changes in pathogens causing early-
onset sepsis in very-low-birth-weight 
infants. N Engl J Med 2002; 
347(4):240-247. PMID: 12140299. 
3 Bizzarro MJ, Dembry LM, Baltimore 
RS, Gallagher PG. Changing patterns 
in neonatal Escherichia coli sepsis and 
ampicillin resistance in the era of 
intrapartum antibiotic prophylaxis. 
Pediatrics 2008; 121(4):689-696. 
PMID: 18381532. 
4 Puopolo KM, Eichenwald EC. No 
change in the incidence of ampicillin-
resistant, neonatal, early-onset sepsis 
over 18 years. Pediatrics 2010; 
125(5):e1031-e1038. PMID: 
20385650. 
5 Marget W, Seeliger HP. Listeria 
monocytogenes infections–therapeutic 
possibilities and problems. Infection 
1988; 16:S175-S177. PMID: 3047067. 
6 Hof H. An update on the medical 
management of listeriosis. Expert Opin 
Pharmacother 2004; 5(8):1727-1735. 
PMID: 15264987. 
7 Cotten CM, Taylor S, Stoll B, et al. 
Prolonged duration of initial empirical 
antibiotic treatment is associated with 
increased rates of necrotizing 
enterocolitis and death for extremely 
low birth weight infants. Pediatrics 
2009; 123(1):58-66. PMID: 19117861. 
8 Alexander VN, Northrup V, Bizzarro 
MJ. Antibiotic exposure in the 
newborn intensive care unit and the 
risk of necrotizing enterocolitis. J 
Pediatr 2011; 159(3): 392-397. PMID: 
21489560. 
9 Weintraub AS, Ferrara L, Deluca L, et 
al. Antenatal antibiotic exposure in 
preterm infants with necrotizing 
enterocolitis. J Perinatol 2012; 
32(9):705-709. PMID: 22157626. 
10 Sheffield MJ, Lambert DK, Baer VL, 
et al. Effect of ampicillin on bleeding 
time in very low birth-weight neonates 
during the first week after birth. J 
Perinatol 2011; 31(7):477-480. PMID: 
21372796. 
11 Sheffield MJ, Lambert DK, Henry E, 
Christensen RD. Effect of ampicillin 
on the bleeding time of neonatal 
intensive care unit patients. J Perinatol 
2010; 30(8): 527-530. PMID: 
20043011. 
12 Ealy M, Lynch KA, Meyer NC, Smith 
RJ. The prevalence of mitochondrial 
mutations associated with 
aminoglycoside-induced sensorineural 
hearing loss in an NICU population. 
Laryngoscope 2011; 121(6):1184-
1186. PMID: 21495045. 
Keywords: neonatology, sepsis, anti-
bacterial agents, ampicillin, piperacillin 
 
